Biliary Tract Cancer
What's New
Last Posted: Oct 27, 2022
- Clinical Implications of BRCA Mutations in Advanced Biliary Tract Cancer.
Kim Hyera et al. Oncology 2022 - Effect of comprehensive cancer genomic profiling on therapeutic strategies and clinical outcomes in patients with advanced biliary tract cancer: A prospective multicenter study.
Takada Kohichi et al. Frontiers in oncology 2022 12988527 - Lessons learned: the first consecutive 1000 patients of the CCCMunich Molecular Tumor Board.
Heinrich Kathrin et al. Journal of cancer research and clinical oncology 2022 - Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants.
Momozawa Yukihide et al. JAMA oncology 2022 - Targeted deep sequencing contributes to guiding personalized targeted therapy for advanced biliary tract cancer patients with non‑radical resection: A real‑world study.
Feng Feiling et al. Oncology reports 2020 Feb - Feasibility of next-generation sequencing in clinical practice: results of a pilot study in the Department of Precision Medicine at the University of Campania 'Luigi Vanvitelli'.
De Falco Vincenzo et al. ESMO open 2020 Mar 5(2) - Biliary tract cancer prognostic and predictive genomics.
Mondaca Sebastian et al. Chinese clinical oncology 2019 Aug 8(4) 42 - Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAs.
Kim Kwondo et al. BMC medical genomics 2019 12(1) 62 - Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker.
Chae Heejung et al. European journal of cancer (Oxford, England : 1990) 2019 Aug 12031-39 - Feasibility of circulating tumor DNA testing in hepatocellular carcinoma.
Mody Kabir et al. Journal of gastrointestinal oncology 2019 Aug 10(4) 745-750
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:May 27, 2023
- Content source: